Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma

NCT02186834 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Selinexor
DRUG: Liposomal doxorubicin
DRUG: Dexamethasone

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]